Article: Q-RNA, Inc. Announces First Blood-based Opportunity for Detection of Prion Diseases in Live Animals; Potential for First Pre-mortum Test for Mad Cow Disease; New Technology Could Be Used to Test Live Animals and Eliminate Current Requirement to Slaughter Animals for Mad Cow Testing.

NEW YORK, Jan. 13 /PRNewswire/ -- Q-RNA, Inc., a privately held biotechnology company, announced today that it has recently validated its disease detection technologies for use with prion diseases such as scrapie in sheep and chronic wasting disease in elk. The company expects to apply its proprietary technology for the development of a new blood-based test for Bovine Spongiform Encephalopathy (BSE) or "mad cow disease." Current mad cow testing technologies require that animals be slaughtered for tissue-based testing to take place. Q-RNA's technologies would potentially make it possible to test larger numbers of animals prior to the onset of symptoms by testing the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!